District Courts Split on Whether Bristol-Myers Squibb’s Specific Personal Jurisdiction Analysis Bars Nationwide Class Actions In Districts Beyond Defendant’s Home Venue

The ramifications of the Supreme Court’s decision in Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco Cty., 137 S. Ct. 1773 (2017), remain unsettled. In Bristol-Myers Squibb, the United States Supreme Court rejected California’s “sliding scale approach” to assertions of specific personal jurisdiction. California’s Supreme Court had addressed a nationwide mass action and […]

Read more detail on Recent Securities Law posts –

Last search terms:

Related news:

This entry was posted in Securities Law and tagged , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply